2invest AG
2invest AG, an investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, IT sectors, and natural resources sectors in Germany and internationally. The company was formerly known as 4basebio AG and changed its name to 2invest AG in January 2021. 2invest AG was founded in 1997 and is based in Heidelberg, German… Read more
2invest AG (2INV) - Net Assets
Latest net assets as of June 2025: €85.12 Million EUR
Based on the latest financial reports, 2invest AG (2INV) has net assets worth €85.12 Million EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€86.63 Million) and total liabilities (€1.50 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €85.12 Million |
| % of Total Assets | 98.26% |
| Annual Growth Rate | 11.52% |
| 5-Year Change | -1.8% |
| 10-Year Change | N/A |
| Growth Volatility | 34.73 |
2invest AG - Net Assets Trend (2019–2024)
This chart illustrates how 2invest AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for 2invest AG (2019–2024)
The table below shows the annual net assets of 2invest AG from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €82.98 Million | +31.40% |
| 2023-12-31 | €63.16 Million | +2.56% |
| 2022-12-31 | €61.58 Million | -25.46% |
| 2021-12-31 | €82.61 Million | -2.24% |
| 2020-12-31 | €84.50 Million | +75.69% |
| 2019-12-31 | €48.10 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to 2invest AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 5584700000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €370.98 Million | 447.06% |
| Total Equity | €82.98 Million | 100.00% |
2invest AG Competitors by Market Cap
The table below lists competitors of 2invest AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
d1000 Varejo Farma Participações S.A
SA:DMVF3
|
$13.68 Million |
|
Hercules Investments Limited
NSE:HERCULES
|
$13.70 Million |
|
Carbonxt Group Ltd
AU:CG1
|
$13.71 Million |
|
IFB Agro Industries Limited
NSE:IFBAGRO
|
$13.71 Million |
|
Pharma Equity Group A/S Cl A
CO:PEG
|
$13.66 Million |
|
Plus Group Holdings Inc.
F:EJ0
|
$13.66 Million |
|
Chin Huay PCL
BK:CH
|
$13.66 Million |
|
Steel Hawk Berhad
KLSE:0320
|
$13.66 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in 2invest AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 63,155,000 to 82,982,000, a change of 19,827,000 (31.4%).
- Net income of 22,159,000 contributed positively to equity growth.
- Share repurchases of 2,331,000 reduced equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €22.16 Million | +26.7% |
| Share Repurchases | €2.33 Million | -2.81% |
| Other Changes | €-1.00K | -0.0% |
| Total Change | €- | 31.39% |
Book Value vs Market Value Analysis
This analysis compares 2invest AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.79x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 12.40x to 0.79x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | €0.92 | €11.40 | x |
| 2020-12-31 | €14.70 | €11.40 | x |
| 2021-12-31 | €14.37 | €11.40 | x |
| 2022-12-31 | €10.71 | €11.40 | x |
| 2023-12-31 | €10.99 | €11.40 | x |
| 2024-12-31 | €14.44 | €11.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently 2invest AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 26.70%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2443.11%
- • Asset Turnover: 0.01x
- • Equity Multiplier: 1.01x
- Recent ROE (26.70%) is above the historical average (8.73%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -5.52% | -252.19% | 0.02x | 1.29x | €-7.46 Million |
| 2020 | 65.13% | 79757.97% | 0.00x | 1.01x | €46.58 Million |
| 2021 | -2.29% | 0.00% | 0.00x | 1.06x | €-10.15 Million |
| 2022 | -34.16% | 0.00% | 0.00x | 1.01x | €-27.19 Million |
| 2023 | 2.50% | 1946.91% | 0.00x | 1.02x | €-4.74 Million |
| 2024 | 26.70% | 2443.11% | 0.01x | 1.01x | €13.86 Million |
Industry Comparison
This section compares 2invest AG's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| 2invest AG (2INV) | €85.12 Million | -5.52% | 0.02x | $13.67 Million |
| Hanna Capital Corp (04U1) | $-79.29K | 0.00% | 0.00x | $116.52K |
| WESTMINSTER RES (08W) | $4.66 Million | -31.33% | 0.12x | $5.16 Million |
| Axonics Inc (0I3) | $570.14 Million | -10.47% | 0.16x | $3.29 Billion |
| Global Bioenergies SA (1DK) | $14.81 Million | -86.04% | 0.89x | $369.68K |
| GIEAG Immobilien AG (2GI) | $41.80 Million | 40.21% | 8.93x | $15.57K |
| PT Central Proteina Prima Tbk (4PT) | $3.42 Trillion | 11.74% | 1.00x | $6.90 Million |
| DGH Deutsche Grundwert Holding AG (5TR) | $0.00 | 0.00% | 0.00x | $18.45K |
| SOFTCHOICE CORP. (90Q) | $58.23 Million | -19.76% | 10.01x | $470.36 Million |
| ALBA SE (ABA) | $142.95 Million | 5.25% | 0.45x | $5.10 Million |